๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This study is a card Rayleigh bead single combined cisplatin treatment of a...
Status
Unknown
Location
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Start Date
2022-08-05
Trial ID
NCT05490485
Treatments Being Tested
The investigators conducted a phase II, prospective, two-arm clinical study...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2023-05-25
Trial ID
NCT05821452
Treatments Being Tested
For patients with metastatic gastric cancer, the efficacy of current standa...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2024-11-14
Trial ID
NCT06711471
Treatments Being Tested
The study is being conducted to evaluate the efficacy and safety of convers...
Status
Completed
Location
Shandong Cancer Hospital and Institute
Start Date
2021-03-17
Trial ID
NCT05099848
Treatments Being Tested
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Status
Completed
Location
Hunan Cancer hospital
Start Date
2019-07-01
Trial ID
NCT05942768
Treatments Being Tested
To evaluate the efficacy and safety of short-course radiotherapy followed b...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-30
Trial ID
NCT07059949
Treatments Being Tested
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2021-09
Trial ID
NCT03766178
Treatments Being Tested
Primary liver cancer is the second most common cause of cancer death in Chi...
Status
Unknown
Location
Multiple Locations
Start Date
2021-09-01
Trial ID
NCT04947956
Treatments Being Tested
Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Status
Recruiting
Location
Chinese PLA General hospital
Start Date
2021-01-01
Trial ID
NCT06333561